For the First Time in Asia, AIIMS Will Conduct Virtual Autopsies for Better Results


The mortuary at All India Institute Of Medical Science has Asia’s first digital radiological unit for doctors to conduct virtual autopsies using high-tech digital X-rays.

The unit can detect even the smallest clots and fractures, in less time.

ct-scan

Virtual Autopsy is a non-intrusive technique for human autopsy. The unit has a Computer Tomography (CT) unit and a Magnetic Resonance Imaging (MRI) unit. These provide a detailed view of the body and the resulting images can be used by medical examiners and pathologists.

“The virtual autopsies are less time consuming as compared to the traditional post mortem and are minimally invasive allowing the body to be released for cremation or burial sooner,” Dr. Sudhir Gupta, head of the AIIMS forensic department, told The Times of India.

He added that virtual autopsies help detect concealed fractures and injuries in decomposed bodies, which is difficult during visual examinations. Virtual autopsy also helps spot hairline and chip fractures, and they can be documented on X-ray films as well, creating permanent, digital records of the body. This makes it easy for forensic pathologists to work on the reports.

Ecstasy trials approved by FDA for PTSD patients.


Turns out Ecstasy could have some medicinal value.

After successful preliminary trials, the FDA is moving forward with a large-scale study for using Ecstasy as a prescription drug to treat post-traumatic stress disorder.

The study approved Tuesday would be the final measure necessary before the agency could legalize the drug, according to the New York Times. If the results are favorable, the drug also known as MDMA would be available to patients as early as 2021.

The trial, sponsored by the Multidisciplinary Association for Psychedelic Studies, reportedly will include 230 participants. Past research funded by the organization has studied the drug’s effect on veterans, sexual assault victims, police and firefighters suffering from PTSD.

“We can sometimes see this kind of remarkable improvement in traditional psychotherapy, but it can take years, if it happens at all,” researcher Michael Mithoefer told the New York Times. “We think it works as a catalyst that speeds the natural healing process.”

One patient suffering from PTSD who participated in a 2012 study on MDMA said the drug allowed her to confront trauma she experienced from sexual abuse as a child.

“It allowed me to rewire my brain,” Rachel Hope told CNN.

But some medical professionals had some reservations about treating patients with Ecstasy. Use of the drug raises concerns about addiction, according to Charles Marmar, head of psychiatry at New York University’s Langone School of Medicine.

“It’s a feel-good drug, and we know people are prone to abuse it,” he told the New York Times. “Prolonged use can lead to serious damage to the brain.”

Dementia now striking people in their 40s as mercury from vaccines causes slow, degenerative brain damage


Victims of Dementia and other neurological brain conditions are getting younger, researchers at Bournemouth University, England have found.

The study, published in the Surgical Neurology International journal states that levels are “almost epidemic,” and environmental factors are thought to be the cause of this.
“The rate of increase in such a short time suggests a silent or even a ‘hidden’ epidemic, in which environmental factors must play a major part, not just ageing,” lead researcher Colin Pritchard said. “Modern living produces multi-interactional environmental pollution but the changes in human morbidity, including neurological disease is remarkable and points to environmental influences.”

The study looked a figures for neurological brain diseases in 21 Western countries from 1989 to 2010. The results showed that as of 2010, the average rate for Dementia to set it was 10 years earlier than in 1989, and that deaths from neurological diseases had a significant increase in those aged between 55 and 74, and had doubled for those over 75.

The changes were seen across the board, but were far worse in the United States. Deaths from neurological conditions in men over 74 tripled between 1989 and 2010, and increased by five times in women. Brain disease has now taken over cancer as the number one cause of death in elderly US women.

The researchers explained,  “Crucially it is not just because people are living longer to get diseases they previously would not have lived long enough to develop but older people are developing neurological disease more than ever before,” Pritchard said.

The findings have instead been attributed to environmental factors.
“The environmental changes in the last 20 years have seen increases in the human environment of petro-chemicals – air transport- quadrupling of motor vehicles, insecticides and rises in background electro-magnetic-field, and so on.”

“These results will not be welcome news as there are many with short-term vested interests that will want to ignore them,” he said.

There is also fears that exposure to mercury from vaccines could be contributing to neurological diseases.
A study in the Journal of Alzheimer’s Disease in 2010,showed that long term exposure to mercury produced the same effects as Alzheimer’s disease, including confusion and reduced cognitive function.

“Mercury is clearly contributing to neurological problems, whose rate is increasing in parallel with rising levels of mercury,” researcher Richard Deth said. “It seems that the two are tied together.”

Tech Firm Will Transfer People’s Consciousness Into Robots.


“Will death always be inevitable? We don’t think so. HumaiTech.com

 

An Australian startup tech company have announced plans to work on a way of transferring a person’s consciousness into a robots body so that people can continue to live after their bodies have died. 

 Tech firm Humai’s CEO Josh Bocanegra says the company wants to “bring you back to life after you die”, claiming that the company are:

using artificial intelligence and nanotechnology to store data of conversational styles, behavioral patterns, thought processes and information about how your body functions from the inside-out.”

“This data will be coded into multiple sensor technologies, which will be built into an artificial body with the brain of a deceased human. Using cloning technology, we will restore the brain as it matures“.

Techspot.com reports:

In an interview with Australian Popular Science, Bocanegra said: “We’ll first collect extensive data on our members for years prior to their death via various apps we’re developing.” After death, the company will cryogenically freeze members’ brains until the technology is fully developed, at which point the brains will be implanted into an artificial body.

“The artificial body functions will be controlled with your thoughts by measuring brain waves. As the brain ages we’ll use nanotechnology to repair and improve cells. Cloning technology is going to help with this too.”

Bocanegra believes, somewhat optimistically, that his company will be able to resurrect the first human within the next 30 years. At the moment, Humai only has four staff but it is looking to recruit more members over the coming months.

A lot of what Humai says is pretty vague when it comes to precise details, and the company seems to be relying on a lot of scientific breakthroughs being made in the near future.

Bocanegra, meanwhile, doesn’t come from a scientific background. He describes himself as “a serial entrepreneur, technology visionary and internet marketer” on his website. Before he started Humai, Bocanegra set up an Airbnb-Meets-OKCupid dating app called LoveRoom that lets two people live together for a week to see if they would be romantically compatible.

 

British man might be first in the world to be cured of HIV after ‘breakthrough’ treatment


Pioneering new therapy launches two-stage ‘kick and kill’ attack on the virus.

A 44-year-old British man may have become the first person in the world to be cured of HIV.

Tests showed the virus had become undetectable in the blood of the previously HIV-positive man, after he was treated with a pioneering new therapy designed to eradicate the virus.

Researchers have cautioned that it is too early to tell if the treatment has really worked but said the man, a social worker, had made “remarkable progress”.

The patient was the first of 50 people to complete a trial of the ambitious treatment which launches a two-stage “kick and kill” attack on the virus.

The new therapy is unique in that it tracks down and destroy HIV in every part of the body —including in the dormant cells that evade current treatments.

“This is one of the first serious attempts at a full cure for HIV,” Mark Samuels of Britain’s National Institute for Health Research told The Sunday Times.

”This is a huge challenge and it’s still early days, but the progress has been remarkable,” he said.

The clinical trials, which are being paid for by the NHS, are the result of a collaboration between doctors and scientists at the universities of Oxford, Cambridge, Imperial College London, University College London and King’s College London.

 The man, who has not been named, said he participated in the trial to help others with the disease.

HIV, which stands for ”human immunodeficiency virus,“ is mainly transmitted through sexual acts or by using infected needles. The virus weakens a person’s immune system by destroying T-cells which are crucial to fighting disease and infection.

About 36.7 million people are living with HIV worldwide, according to the US Centers for Disease Control and Prevention.

Antiretroviral therapies target and suppress active infected cells but they leave millions of dormant infected T-cells lying in wait throughout the body. This means existing treatments can effectively control HIV but do not cure the disease.

The new treatment, however, would both suppress infections and kill the reservoir of dormant cells, The Sunday Times reported.

Sarah Fidler, a consultant physician and professor at Imperial College London, said medical tests of the potentially breakthrough therapy would continue for the next five years.

”It has worked in the laboratory and there is good evidence it will work in humans too,“ Ms Fidler said. ”But we must stress that we are still a long way from any actual therapy.”

Cold Plasma Can Help Treat Non-Healing Wounds and Trigger Cellular Regeneration


IN BRIEF

Research by Russian scientists has revealed the efficacy of cold plasma as a treatment for non-healing wounds. Their study conclusions could lead to much-needed relief for the millions of people suffering from chronic open wounds.

A CHILLY DISCOVERY

Non-healing wounds are troublesome to treat, with current methods teetering between extremely difficult and impossible, but cold plasma might be able to change all that.

Researchers have attempted to use cold atmospheric-pressure plasma — a partially ionized gas with a proportion of charged particles close to 1 percent and a temperature of 99,726°C (179,540ºF) — for medical treatment before, but never specifically for non-healing wounds. Apart from confirming the bactericidal properties of cold plasma and showing that cells and tissues have a high resistance to it, those earlier studies yielded non-conclusive results.

By focusing on application pattern, a team of researchers from Russia’s Moscow Institute of Physics and Technology (MIPT) were able to reach more definite conclusions, establishing that cold plasma could indeed help heal non-healing wounds and trigger cellular regeneration.

To test their hypothesis that application was key, the researchers studied the effects of cold plasma treatment using two kinds of cells (connective tissue cells called fibroblasts and epithelial cells called keratinocytes) and three regimes of application. They were able to conclude that a single application was most effective in triggering regeneration and also observed that plasma treatment significantly reduced the levels of β-galactosidase, an enzyme that triggers cellular aging, in their samples.

Credit: MIPT

RELIEF, FINALLY.

These results mean that the effect of plasma treatment can now be characterized as regenerative, as opposed to just neutral or even harmful. This opens doors for further research in the area and could lead to the development of a plasma therapy program for the reported 5.7 million patients suffering from open (chronic) wounds.

In their future research, the scientists are planning to look into the molecular mechanisms underlying the effects of plasma on cells and will also attempt to determine what impact, if any, a patient’s age has on the effectiveness of plasma therapy.

If this research is any indication, a whole lot of people may experience an improved quality of life thanks to cold plasma therapy in the future.

Researchers create first ‘water-wave laser’ 


Researchers have demonstrated that laser emissions can be created through the interaction of light and water waves. This ‘water-wave laser’ could someday be used in tiny sensors or ‘lab-on-a-chip’ devices used to test new drug therapies.
 

Technion researchers have demonstrated, for the first time, that laser emissions can be created through the interaction of light and water waves. This “water-wave laser” could someday be used in tiny sensors that combine light waves, sound and water waves, or as a feature on microfluidic “lab-on-a-chip” devices used to study cell biology and to test new drug therapies.

For now, the water-wave laser offers a “playground” for scientists studying the interaction of light and fluid at a scale smaller than the width of a human hair, the researchers write in the new report, published November 21 in Nature Photonics.

The study was conducted by Technion-Israel Institute of Technology students Shmuel Kaminski, Leopoldo Martin, and Shai Maayani, under the supervision of Professor Tal Carmon, head of the Optomechanics Center at the Mechanical Engineering Faculty at Technion. Carmon said the study is the first bridge between two areas of research that were previously considered unrelated to one another: nonlinear optics and water waves.

A typical laser can be created when the electrons in atoms become “excited” by energy absorbed from an outside source, causing them to emit radiation in the form of laser light. Professor Carmon and his colleagues now show for the first time that water wave oscillations within a liquid device can also generate laser radiation.

The possibility of creating a laser through the interaction of light with water waves has not been examined, Carmon said, mainly due to the huge difference between the low frequency of water waves on the surface of a liquid (approximately 1,000 oscillations per second) and the high frequency of light wave oscillations (1014 oscillations per second). This frequency difference reduces the efficiency of the energy transfer between light and water waves, which is needed to produce the laser emission.

To compensate for this low efficiency, the researchers created a device in which an optical fiber delivers light into a tiny droplet of octane and water. Light waves and water waves pass through each other many times (approximately one million times) inside the droplet, generating the energy that leaves the droplet as the emission of the water-wave laser.

The interaction between the fiber optic light and the miniscule vibrations on the surface of the droplet are like an echo, the researchers noted, where the interaction of sound waves and the surface they pass through can make a single scream audible several times. In order to increase this echo effect in their device, the researchers used highly transparent, runny liquids, to encourage light and droplet interactions.

Furthermore, a drop of water is a million times softer than the materials used in current laser technology. The minute pressure applied by light can therefore cause droplet deformation that is a million times greater than in a typical optomechanical device, which may offer greater control of the laser’s emissions and capabilities, the Technion scientists said.

Geologist uncovers 2.5 billion-year-old fossils of bacteria that predate the formation of oxygen


Life before oxygen
A microscopic image of 2.5 billion-year-old sulfur-oxidizing bacterium. 

Somewhere between Earth’s creation and where we are today, scientists have demonstrated that some early life forms existed just fine without any oxygen.

 While researchers proclaim the first half of our 4.5 billion-year-old planet’s life as an important time for the development and evolution of early bacteria, evidence for these life forms remains sparse including how they survived at a time when oxygen levels in the atmosphere were less than one-thousandth of one percent of what they are today.

Recent geology research from the University of Cincinnati presents new evidence for bacteria found fossilized in two separate locations in the Northern Cape Province of South Africa.

“These are the oldest reported fossil sulfur bacteria to date,” says Andrew Czaja, UC assistant professor of geology. “And this discovery is helping us reveal a diversity of life and ecosystems that existed just prior to the Great Oxidation Event, a time of major atmospheric evolution.”

The 2.52 billion-year-old sulfur-oxidizing bacteria are described by Czaja as exceptionally large, spherical-shaped, smooth-walled microscopic structures much larger than most modern bacteria, but similar to some modern single-celled organisms that live in deepwater sulfur-rich ocean settings today, where even now there are almost no traces of oxygen.

Life before oxygen
UC Professor Andrew Czaja indicates the layer of rock from which fossil bacteria were collected on a 2014 field excursion near the town of Kuruman in the Northern Cape Province of South Africa. 

In his research published in the December issue of the journal Geology of the Geological Society of America, Czaja and his colleagues Nicolas Beukes from the University of Johannesburg and Jeffrey Osterhout, a recently graduated master’s student from UC’s department of geology, reveal samples of bacteria that were abundant in deep water areas of the ocean in a geologic time known as the Neoarchean Eon (2.8 to 2.5 billion years ago).

“These fossils represent the oldest known organisms that lived in a very dark, deep-water environment,” says Czaja. “These bacteria existed two billion years before plants and trees, which evolved about 450 million years ago. We discovered these microfossils preserved in a layer of hard silica-rich rock called chert located within the Kaapvaal craton of South Africa.”

With an atmosphere of much less than one percent oxygen, scientists have presumed that there were things living in deep water in the mud that didn’t need sunlight or oxygen, but Czaja says experts didn’t have any direct evidence for them until now.

 Czaja argues that finding rocks this old is rare, so researchers’ understanding of the Neoarchean Eon are based on samples from only a handful of geographic areas, such as this region of South Africa and another in Western Australia.
According to Czaja, scientists through the years have theorized that South Africa and Western Australia were once part of an ancient supercontinent called Vaalbara, before a shifting and upending of tectonic plates split them during a major change in the Earth’s surface.

Based on radiometric dating and geochemical isotope analysis, Czaja characterizes his fossils as having formed in this early Vaalbara supercontinent in an ancient deep seabed containing sulfate from continental rock. According to this dating, Czaja’s fossil bacteria were also thriving just before the era when other shallow-water bacteria began creating more and more oxygen as a byproduct of photosynthesis.

“We refer to this period as the Great Oxidation Event that took place 2.4 to 2.2 billion years ago,” says Czaja.

Life before oxygen
Microstructures here have physical characteristics consistent with the remains of compressed coccodial (round) bacteria microorganisms. Credit: Andrew Czaja, permission to publish by Geological Society of America

Early recycling

Czaja’s fossils show the Neoarchean bacteria in plentiful numbers while living deep in the sediment. He contends that these early bacteria were busy ingesting volcanic hydrogen sulfide—the molecule known to give off a rotten egg smell—then emitting sulfate, a gas that has no smell. He says this is the same process that goes on today as modern bacteria recycle decaying organic matter into minerals and gases.

“The waste product from one [bacteria] was food for the other,” adds Czaja.

“While I can’t claim that these early bacteria are the same ones we have today, we surmise that they may have been doing the same thing as some of our current bacteria,” says Czaja. “These early bacteria likely consumed the molecules dissolved from sulfur-rich minerals that came from land rocks that had eroded and washed out to sea, or from the volcanic remains on the ocean’s floor.

There is an ongoing debate about when sulfur-oxidizing bacteria arose and how that fits into the earth’s evolution of life, Czaja adds. “But these fossils tell us that sulfur-oxidizing were there 2.52 billion years ago, and they were doing something remarkable.”

Inside tiny tubes, water turns solid when it should be boiling.


A team at MIT has found an unexpected discovery about water: Inside the tiniest of spaces — in carbon nanotubes whose inner dimensions are not much bigger than a few water molecules — water can freeze solid even at high temperatures that would normally set it boiling. The finding might lead to new applications such as ice-filled wires.

MIT researchers discover astonishing behavior of water confined in carbon nanotubes

It’s a well-known fact that water, at sea level, starts to boil at a temperature of 212 degrees Fahrenheit, or 100 degrees Celsius. And scientists have long observed that when water is confined in very small spaces, its boiling and freezing points can change a bit, usually dropping by around 10 C or so.

But now, a team at MIT has found a completely unexpected set of changes: Inside the tiniest of spaces — in carbon nanotubes whose inner dimensions are not much bigger than a few water molecules — water can freeze solid even at high temperatures that would normally set it boiling.

The discovery illustrates how even very familiar materials can drastically change their behavior when trapped inside structures measured in nanometers, or billionths of a meter. And the finding might lead to new applications — such as, essentially, ice-filled wires — that take advantage of the unique electrical and thermal properties of ice while remaining stable at room temperature.

The results are being reported today in the journal Nature Nanotechnology, in a paper by Michael Strano, the Carbon P. Dubbs Professor in Chemical Engineering at MIT; postdoc Kumar Agrawal; and three others.

“If you confine a fluid to a nanocavity, you can actually distort its phase behavior,” Strano says, referring to how and when the substance changes between solid, liquid, and gas phases. Such effects were expected, but the enormous magnitude of the change, and its direction (raising rather than lowering the freezing point), were a complete surprise: In one of the team’s tests, the water solidified at a temperature of 105 C or more. (The exact temperature is hard to determine, but 105 C was considered the minimum value in this test; the actual temperature could have been as high as 151 C.)

“The effect is much greater than anyone had anticipated,” Strano says.

It turns out that the way water’s behavior changes inside the tiny carbon nanotubes — structures the shape of a soda straw, made entirely of carbon atoms but only a few nanometers in diameter — depends crucially on the exact diameter of the tubes. “These are really the smallest pipes you could think of,” Strano says. In the experiments, the nanotubes were left open at both ends, with reservoirs of water at each opening.

Even the difference between nanotubes 1.05 nanometers and 1.06 nanometers across made a difference of tens of degrees in the apparent freezing point, the researchers found. Such extreme differences were completely unexpected. “All bets are off when you get really small,” Strano says. “It’s really an unexplored space.”

In earlier efforts to understand how water and other fluids would behave when confined to such small spaces, “there were some simulations that showed really contradictory results,” he says. Part of the reason for that is many teams weren’t able to measure the exact sizes of their carbon nanotubes so precisely, not realizing that such small differences could produce such different outcomes.

In fact, it’s surprising that water even enters into these tiny tubes in the first place, Strano says: Carbon nanotubes are thought to be hydrophobic, or water-repelling, so water molecules should have a hard time getting inside. The fact that they do gain entry remains a bit of a mystery, he says.

Strano and his team used highly sensitive imaging systems, using a technique called vibrational spectroscopy, that could track the movement of water inside the nanotubes, thus making its behavior subject to detailed measurement for the first time.

The team can detect not only the presence of water in the tube, but also its phase, he says: “We can tell if it’s vapor or liquid, and we can tell if it’s in a stiff phase.” While the water definitely goes into a solid phase, the team avoids calling it “ice” because that term implies a certain kind of crystalline structure, which they haven’t yet been able to show conclusively exists in these confined spaces. “It’s not necessarily ice, but it’s an ice-like phase,” Strano says.

Because this solid water doesn’t melt until well above the normal boiling point of water, it should remain perfectly stable indefinitely under room-temperature conditions. That makes it potentially a useful material for a variety of possible applications, he says. For example, it should be possible to make “ice wires” that would be among the best carriers known for protons, because water conducts protons at least 10 times more readily than typical conductive materials. “This gives us very stable water wires, at room temperature,” he says.

Many LASIK patients may wind up with glare, halos or other visual symptoms, study suggests


LASIK isn’t always as awesome as we might think.

Millions of Americans each year undergo LASIK surgery to correct their vision. Given how common the procedure has become and how ubiquitous the ads are on radio and TV, you might be tempted to treat the decision to get the treatment pretty casually or think of it as purely a financial decision. A team of researchers from the Food and Drug Administration, the National Eye Institute and the Department of Defense would like to make sure you weigh the potential risks to your eyes more seriously.

In 2009, as LASIK was becoming a household word, the government scientists launched a major study to investigate reports of adverse impacts from the procedure. At the time, there were a lot of anecdotes flying around but little scientific information about patient outcomes. The results, published in October 2014, showed that some patients developed problems that adversely affected their day-to-day lives, such as difficulty driving at night or in sunshine. But it was such a small number — less than 1 percent — of the patients in the study that it was difficult to draw any strong conclusions from that data.

On Wednesday, the group released a follow-up report in JAMA Ophthalmology that provides more sobering information. The study suggests that the percentage of people who undergo LASIK and wind up with new visual symptoms — such as double images, glare, halos or starbursts — may be much higher. The data was based on a questionnaire that looked at patient satisfaction with their vision and at visual and dry-eye symptoms following surgery.

First, the good news. More than 95 percent of participants said they were satisfied with the improvements to their vision. In addition, the prevalence of dry-eye symptoms also decreased after surgery. The bad news is that a “substantial” percentage of the study participants said they had other, new symptoms following the procedure.

The study analyzed outcomes for two groups of LASIK patients. In the first group, which included 262 Navy personnel with an average age of 29.1, it was 43 percent reporting new symptoms. And in the second, consisting of 312 civilians at five practice and academic centers and with a median age of 31.5, it was 46 percent. In addition, about 28 percent of patients who had never had dry-eye symptoms before developed mild, moderate or severe symptoms three months after the procedure.

“To our knowledge, our study is one of the few that have reported the development of new visual symptoms,” Malvina Eydelman of the U.S. Food and Drug Administration and colleagues wrote. “While the overall prevalence of visual symptoms decreased, a large percentage of participants with no symptoms preoperatively reported new visual symptoms postoperatively.”

One interesting component of this study was that the survey showed that the percentage of people with symptoms may be much higher than what has been previously reported in studies involving direct interviews with health-care professionals. The authors of the new study note that the reluctance of patients to tell their doctors about “negative” events has been well documented.

The researchers cautioned that the study may not generalize to the LASIK population as a whole because of its small sample size and short follow-period, which was typically three months. However, they emphasized that “although the magnitude of the development of symptoms is uncertain, patients undergoing LASIK surgery should be adequately counseled about the possibility of developing new visual symptoms after surgery prior to undergoing this elective procedure.”